Medtronic has been hiking its dividend for nearly 50 consecutive years. It's spinning off its diabetes division to focus on faster-growing businesses. Its strategy makes sense -- and its valuation is ...

Neuroscience Portfolio revenue of $2.558 billion, an increase of 4.1% reported and 2.5% organic, with a mid-single digit increase in Neuromodulation, a mid-single digit increase in Cranial & Spinal ...

Shares drop 2.6% despite beating quarterly expectations Company expects $300 million hit from tariffs in fiscal 2027 CEO says Danaher-Masimo deal will not change patient-monitoring market long term ...

Medtronic and Mindray North America expanded their partnership on patient monitoring technology beyond hospitals into ASCs in the United States, according to a Jan. 22 news release. The companies said ...

Four years ago, CathWorks and Medtronic plc, one of the world’s largest medical device makers, struck up a co-promotion agreement with the option for Medtronic to buy the Irvine-based cardiac-focused ...

Medical device company Applied Medical has been awarded $381,705,005 in damages after a federal jury in California found Medtronic liable for violations of federal and state antitrust laws. In ...

Feb 5 (Reuters) - Medtronic (MDT.N), opens new tab owes rival medical device manufacturer Applied Medical Resources $382 million in damages for unlawfully monopolizing the market for blood-vessel ...

Applied Medical is based in Rancho Santa Margarita. Medtronic has been ordered by a California federal jury today to pay nearly $382 million to rival medical device maker Applied Medical. Rancho Santa ...

Three University of Colorado campuses, including CU Boulder, announced a partnership on Thursday with the global healthcare technology company Medtronic aimed at accelerating the development of new ...

Medtronic has plans to purchase $90 million worth of shares in Anteris Technologies Global, a company that specializes in the development of transcatheter aortic valve replacement devices. Medtronic’s ...

While the 2026 J.P. Morgan Healthcare Conference has thus far failed to yield any major M&A deals for the industry, Medtronic believes the time is ripe for buyouts. At last year’s JPM event, Medtronic ...

Medtronic Chairman and CEO Geoff Martha joins 'Mad Money' host Jim Cramer at the JPMorgan Health Care Conference to talk its recent growth and opportunities ahead. Got a confidential news tip? We want ...